Refractory Malignant Neoplasm

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB00026Anakinra1Active Not Recruiting1
DB11794Berzosertib1Recruiting1
DB00112Bevacizumab1Recruiting1
DB00002Cetuximab1Recruiting1
DB08865Crizotinib1Active Not Recruiting1
DB06643Denosumab1Active Not Recruiting1
DB01590Everolimus1Active Not Recruiting1
DB00762Irinotecan1Recruiting1
DB12340Navitoclax1Recruiting1
DB09037Pembrolizumab1Recruiting1
DB00398Sorafenib1Active Not Recruiting1
DB00398Sorafenib1Recruiting1
DB06287Temsirolimus1Recruiting1
DB00313Valproic Acid1Recruiting1
DB08881Vemurafenib1Active Not Recruiting1
DB08916Afatinib2Recruiting1
DB00493Cefotaxime2Recruiting1
DB08865Crizotinib2Recruiting1
DB00531Cyclophosphamide2Recruiting1
DB08912Dabrafenib2Recruiting1
DB01254Dasatinib2Recruiting1
DB01073Fludarabine2Recruiting1
DB09035Nivolumab2Recruiting1
DB09330Osimertinib2Recruiting1
DB09073Palbociclib2Recruiting1
DB06366Pertuzumab2Recruiting1
DB11836Sapanisertib2Recruiting1
DB01268Sunitinib2Recruiting1
DB08911Trametinib2Recruiting1
DB00072Trastuzumab2Recruiting1
DB05773Trastuzumab emtansine2Recruiting1
DB08828Vismodegib2Recruiting1